RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

2026-09-29 21:01
RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues
RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

Ophthalmologist-developed and clinically tested, the new peptide-powered formula pairs advanced time-release technology with high-performance lash conditioning

VENTURA, Calif., Sept. 29, 2026 /PRNewswire/ -- RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair care, is advancing lash innovation once again with the launch of RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, the world's first time-release multi-peptide lash conditioning serum developed by an ophthalmologist.

RevitaLash Peptide Complex+ Time Release Eyelash Conditioner
RevitaLash Peptide Complex+ Time Release Eyelash Conditioner

Scientifically advanced and clinically tested, the new formula offers a high-performance approach to lash conditioning for consumers seeking the look of stronger, healthier, more bold and resilient lashes without the use of prostaglandins.

At the heart of the formula is RevitaLash Peptide Complex, featuring Revitasome® Technology, Troxerutin and MP17, which combines a protective antioxidant with a biomimetic signal peptide in a time-release liposomal delivery system. Designed to release over eight hours for gentle, optimal absorption into the eyelashes, the peptide-dense, nutrient-rich formula helps support the appearance of natural lash volume while reinforcing strength to help decrease the appearance of fallout and breakage. The result: lashes that look shinier, stronger, more flexible and beautifully conditioned.

"We are proud of this first-of-its kind expansion to our lash serum collection with a formula that brings together advanced science and innovative time-release technology to meet the evolving needs of today's consumer," said Lori Jacobus, President and Global CMO of RevitaLash® Cosmetics. "RevitaLash Peptide Complex+ offers a new way to achieve the look of stronger, healthier, beautifully conditioned lashes while delivering the performance, innovation and expertise consumers have come to expect from RevitaLash Cosmetics."

In a 12-week consumer study of 160 users, RevitaLash Peptide Complex+ delivered visible improvements in the appearance and condition of lashes. After just six weeks, 90% of participants reported improved lash appearance and 90% reported healthier-looking lashes. Additionally, 89% saw enhanced lash appearance at six weeks, increasing to 92% at 12 weeks, while 89% felt their lashes were more nourished at six weeks, increasing to 96% at 12 weeks.

The launch expands RevitaLash Cosmetics' trusted portfolio of lash conditioners, joining RevitaLash® Advanced, RevitaLash® Advanced Sensitive and RevitaLash® Advanced Pro Eyelash Conditioner, and giving consumers even more choice within the brand's science-backed lash care collection.

RevitaLash Peptide Complex+ is ophthalmologist-developed, dermatologist-reviewed, hypoallergenic, non-irritating, vegan-friendly and cruelty-free. The formula is also made without parabens, phthalates, gluten, oil and prostaglandin analogues.

RevitaLash Peptide Complex+ Time Release Eyelash Conditioner (4.0 mL / 0.135 fl. oz.) retails for a suggested price of $90.00 and will be available globally beginning 1 October 2026 through authorized salons, spas, specialty retailers and revitalash.com.

RevitaLash Cosmetics is a worldwide leader in developing premium advanced lash, brow and hair beautification products. Founded in 2006 by ophthalmologist Michael Brinkenhoff, M.D., the brand was inspired by his desire to help his wife feel beautiful during her battle with breast cancer. Today, RevitaLash Cosmetics is available in more than 70 countries and is recognized globally for its award-winning products, leading innovation, commitment to safety and its give-back mission supporting breast cancer initiatives through its longstanding Eternally Pink® pledge that has contributed over $14 million to date.

Latest
On World School Milk Day, Tetra Pak Highlights the Role of Technology in Strengthening School Feeding Programmes
Beijing Watch | Two Chinas Arrived In Washington With Xi Jinping
Yellow.ai Launches Nexus EDGE, the Agentic Desktop Interface That Resolves Employee IT, HR, and Operations Issues -- Not Just Answers Them
Ampace Launches AIDC Battery Solutions White Paper, Exploring the Evolving Role of Batteries Beyond Backup Power
Nvidia Takes AI Agent Security to the Chip With OpenShell, Sentry
5,600 Bags Stranded As Thai Airways Slashes Bangkok Flights
After Trump and Xi Meet Again, Taiwan Is Left to Manage Its Own Risk
COSMOBEAUTÉ MALAYSIA & BEAUTYEXPO 2026 OPENS AT KLCC, CONNECTING BEAUTY BUSINESSES TO REGIONAL GROWTH
Nvidia Boosts Buyback Authorization to a Record $235 Billion
TSMC Eyes Texas for Six New Fabs as Taiwan Packaging Push Doubles
Taiwan Moves to Ban Pro China Party as It Fields 15 Candidates
Sumsub Agentic AI Council Launches in APAC and Invites Experts to Advance Trusted AI Adoption
Furniture China and Maison Shanghai 2026 Conclude on a High Note in Pudong, Shanghai
Taiwan Claims Crown as World's Most Trusted Chip Hub
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
MediaTek Bets on Google's Untested Googlebook With New 3nm Chip
Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis
Pablo Larraín's My Sad Dead Brings Argentina's Ghosts to Netflix
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
Octopus (APAC) Holdings' subsidiary ODN to manage Cellarbration retail and online channels
Bybit and Franklin Templeton Form Strategic Collaboration to Expand Access to Tokenized Investing
SuperX (NASDAQ: SUPX) Launches AI Token Platform and AI Apps at Tech Week Singapore 2026
Cheng Yi Named C-Drama's No. 1 'Broken' Leading Man, Beating Xiao Zhan
MIFF 2027 EVOLVES WITH NEW DESIGN-FOCUSED EXPERIENCES AND WIDER INTERNATIONAL REACH